Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Gregory Raymond Delost , DO

Dermatology • Mayfield Heights, OH

Active NPI 1073995791 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

5800 Landerbrook Dr Ste 250
Mayfield Heights, OH 441244047

Call 4406461600 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

5800 Landerbrook Dr Ste 250

Mayfield Heights, OH 441244047

Telephone 4406461600
Fax 4406461505
Organization at the Same NPPES Address or Phone
Apex Dermatology And Skin Surgery Center, Llc Facility NPI 1689973638

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Optima Dermatology Llc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

Lake Erie College Of Osteopathic Medicine, Erie

Graduation Year

2015

Medicare patients

846 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $285,160 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $203,786 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

2,614 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$174,003 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $163,815.40 across 254 records.

By nature of payment (3 largest of 6)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $115,631.26 across 41 records.
  • Consulting Fee: $22,912.50 across 8 records.
  • Honoraria: $16,250.00 across 9 records.

Reporting-company totals (3 largest of 19)

  • Janssen Pharmaceuticals, Inc: $95,317.38 across 92 records.
  • Incyte Corporation: $27,234.05 across 51 records.
  • Arcutis Biotherapeutics, Inc.: $23,157.46 across 18 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

11 years (graduated 2015)

CMS Doctors and Clinicians data list 2015 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2015

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Delost has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Delost as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Mayfield Heights and Ohio

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 75% of clinicians listed under Dermatology in Ohio (2024, 363 clinicians with data). Median for this group: 2,065. Middle half: 1,076 to 3,673.

Too few clinicians listed under Dermatology in Mayfield Heights have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 80% of clinicians listed under Dermatology in Ohio (2024, 363 clinicians with data). Median for this group: $137,240. Middle half: $69,184 to $237,264.

Too few clinicians listed under Dermatology in Mayfield Heights have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 80% of clinicians listed under Dermatology in Ohio (2024, 363 clinicians with data). Median for this group: $91,114. Middle half: $47,586 to $169,550.

Too few clinicians listed under Dermatology in Mayfield Heights have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Dermatology in Ohio (2024, 398 clinicians with data). Median for this group: 644. Middle half: 280 to 1,144.

Too few clinicians listed under Dermatology in Mayfield Heights have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 60% of clinicians listed under Dermatology in Ohio (2024, 398 clinicians with data). Median for this group: $99,003. Middle half: $10,227 to $354,602.

Too few clinicians listed under Dermatology in Mayfield Heights have Medicare Part D data for 2024 to compare.

3 active clinicians are listed under Dermatology with a practice address in Mayfield Heights, OH (508 in Ohio).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 254 records totaling $163,815.40.

Manufacturer Payment Nature Product Type Amount ($)
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $5,250.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $5,250.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $5,250.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $5,250.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $5,250.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $5,250.00
Arcutis Biotherapeutics, Inc.
Consulting Fee
Cash or cash equivalent
Zoryve General $4,225.00
LNHC, Inc
Honoraria
Cash or cash equivalent
ZELSUVMI General $3,575.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,375.00
Arcutis Biotherapeutics, Inc.
Consulting Fee
Cash or cash equivalent
Zoryve General $2,925.00
Arcutis Biotherapeutics, Inc.
Consulting Fee
Cash or cash equivalent
Zoryve General $2,925.00

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2019–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
17003 Destruction of precancer skin growth, 2-14 growths
846 157 $10.08 $6.08
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
568 369 $139.54 $85.25
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
471 282 $197.71 $119.87
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
422 67 $1.74 $0.98
17000 Destruction of precancer skin growth, 1 growth
335 259 $102.80 $49.98
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
302 302 $173.70 $105.32
17110 Destruction of skin growth, 1-14 growths
226 182 $172.53 $95.26
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
160 160 $258.56 $156.79
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
94 86 $186.59 $96.07
11900 Injection into skin growth, 1-7 growths
91 56 $87.54 $46.58
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
84 81 $209.95 $118.91
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
56 49 $210.13 $121.07
17111 Destruction of skin growth, 15 or more growths
49 34 $202.26 $117.89
17004 Destruction of precancer skin growth, 15 or more growths
44 36 $258.62 $154.87
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
35 30 $654.64 $381.87
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
31 28 $430.21 $129.63
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
30 29 $188.35 $95.98
11312 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
26 26 $240.50 $143.81
13101 Complicated repair of wound of trunk, 2.6-7.5 cm
22 22 $610.96 $340.77
11307 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
15 13 $213.90 $115.25
11104 Punch biopsy, first skin growth
12 11 $191.70 $105.35
11403 Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm
12 12 $304.72 $91.94
11303 Shaving of skin growth of body, arms, or legs, more than 2.0 cm
11 11 $233.58 $121.14

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Triamcinolone Acetonide Triamcinolone Acetonide 420 13,337 $4,522.01 268
Clobetasol Propionate Clobetasol Propionate 384 11,331 $14,446.36 203
Ketoconazole Ketoconazole 323 9,795 $4,512.48 144
Doxycycline Hyclate Doxycycline Hyclate 209 5,284 $4,996.41 143
Prednisone Prednisone 201 4,083 $662.31 134
Mupirocin Mupirocin 149 3,141 $1,205.93 82
Fluconazole Fluconazole 143 4,169 $2,641.13 59
Minoxidil Minoxidil 54 3,890 $302.68 16
Desonide Desonide 40 1,245 $1,868.43 35
Terbinafine Hcl Terbinafine Hcl 40 2,790 $686.88 21
Metronidazole Metronidazole 35 1,070 $1,789.50 27
Clindamycin Phosphate Clindamycin Phosphate 34 1,000 $1,602.78 24
Dutasteride Dutasteride 27 1,879 $539.17 —
Opzelura Ruxolitinib Phosphate 25 750 $51,166.61 —
Betamethasone Valerate Betamethasone Valerate 21 590 $545.75 15
Dupixent Pen Dupilumab 21 588 $78,820.85 —
Cephalexin Cephalexin 20 488 $951.49 13
Valacyclovir Valacyclovir Hcl 18 385 $779.99 16
Hydroxyzine Hcl Hydroxyzine Hcl 17 510 $117.71 —
Spironolactone Spironolactone 15 810 $226.77 —
Finasteride Finasteride 14 1,135 $91.19 —
Hydroxychloroquine Sulfate Hydroxychloroquine Sulfate 13 1,020 $422.42 —
Tretinoin Tretinoin 13 390 $907.82 —
Doxycycline Monohydrate Doxycycline Monohydrate 11 566 $196.09 —

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2022-09-01
Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES OH 34.013691

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: State Medical Board of Ohio.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20190816002208

Enrollment State Jurisdiction

OH

PECOS Control ID

3274831805

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Optima Dermatology Llc

987 Boardman Canfield Rd, Boardman, OH 445124222

Phone: 3309658760

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

7 listed
NPI 1952519043

Doctor of Medicine (M.D.)

Michelle Cheselka , PA

Physician Assistant

NPI 1316622962

Physician Assistant

Dr. Hong Jiang , MD

Pathology - Anatomic Pathology & Clinical Pathology

NPI 1548794225

Doctor of Medicine (M.D.)

NPI 1942468582

Doctor of Medicine (M.D.)

Trent Marburger

Pathology - Dermatopathology

NPI 1457593501
NPI 1033474598

Doctor of Osteopathic Medicine (D.O.)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

8 Historical Events
📍
Updated Practice Location September 01, 2022

Registered at 5800 LANDERBROOK DR STE 250, MAYFIELD HEIGHTS, OH 441244047 (Tel: 4406461600)

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) September 01, 2022

Dermatology (license number reported to NPPES: OH 34.013691)

✅
NPI Profile Active June 19, 2015

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) June 19, 2015

Registered at 130 LAKESHORE DR, STRUTHERS, OH 444711454 (Tel: 3307204259)

📍
Business Mailing Address (Initial Record) June 19, 2015

Registered at 130 LAKESHORE DR, STRUTHERS, OH 444711454 (Tel: 3307204259)

👤
Provider Name / Credentials (Initial Record) June 19, 2015

Recorded as GREGORY DELOST, D.O.

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) June 19, 2015

Student in an Organized Health Care Education/Training Program

🟢
Initial NPI Registration & Enumeration June 19, 2015

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1073995791
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: June 19, 2015
Last Update: September 01, 2022
Sole Proprietor: No

Other Dermatology Specialists in Mayfield Heights

Healthcare providers in Mayfield Heights

More public profiles in Ohio

Directory navigation, in NPI number order.

Mailing Address

130 Lakeshore Dr

Struthers, OH 444711454

Phone: 3307204259

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.